Raviraj Kulathila

Novartis (United States)

Papers

1

Total Citations

17

H-Index

1

About

Raviraj Kulathila is a structural biologist and biophysicist whose research centers on accelerating drug discovery through innovative crystallographic and microfluidic technologies. His most notable contribution is the development of a capillary-based microfluidic device that enables primary high-throughput room-temperature crystallographic screening, published in 2021 and cited 17 times. This work addresses a critical bottleneck in small-molecule compound screening by allowing protein crystals to be analyzed at room temperature using ultra-thin, UV-curable polymer devices patterned via cleanroom photolithography. By streamlining the process of X-ray crystallography, Kulathila’s approach reduces the time and cost associated with traditional cryogenic methods, offering a practical solution for early-stage drug development. His achievements highlight a commitment to bridging engineering and structural biology, making high-throughput screening more accessible. With a growing citation record, Kulathila’s work is poised to influence both academic research and pharmaceutical applications, particularly in fragment-based drug design and structure-guided lead optimization.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
A capillary-based microfluidic device enables primary high-throughput room-temperature crystallographic screening
17 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Novartis (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago